NCT01648283View on ClinicalTrials.gov

CYP2B6 Polymorphisms in Methadone Disposition

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

IV racemic methadone HCl

IV racemic Methadone HC1 6 mg

DRUG

Oral racemic methadone HCl

oral d5-methadone HCl 11 mg

Trial Locations (1)

63110

Washington University Schoool of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01648283 - CYP2B6 Polymorphisms in Methadone Disposition | Biotech Hunter | Biotech Hunter